Comparison of early clinical outcomes between SuperCap and direct anterior approaches for total hip arthroplasty.
10.12200/j.issn.1003-0034.2023.11.005
- Author:
Wen-Ju CHANG
1
,
2
;
Hai DING
1
,
2
;
Fen-Dou LIU
1
,
2
;
Xiang LI
1
,
2
;
Xin-She ZHOU
1
,
2
;
Li-Jia PEI
1
,
2
;
Yang LIU
1
,
2
;
Zhi-Yan WANG
1
,
2
Author Information
1. Department of Orthopedics, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui, China
2. Key Laboratory of Anhui Province for Tissue Transplantation, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui, China.
- Publication Type:Journal Article
- Keywords:
Direct anterior approach;
Minimally invasive;
Superior capsulotomy approach;
Total hip arthroplasty
- MeSH:
Male;
Female;
Humans;
Middle Aged;
Aged;
Arthroplasty, Replacement, Hip;
Retrospective Studies;
Antiviral Agents;
Treatment Outcome;
Creatine Kinase;
Hemoglobins
- From:
China Journal of Orthopaedics and Traumatology
2023;36(11):1030-1035
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To compare the short-term clinical efficacy of SuperCap approach and direct anterior approach in total hip arthroplasty.
METHODS:Clinical data of 70 patients who underwent minimally invasive SuperCap approach and DAA THA in January 2016 to June 2017 were retrospective analyzed. These patients were divided into two groups:SuperCap approach group(SuperCap group) and direct anterior approach group(DAA group). There were 15 males and 15 females in SuperCap group, aged from 45 to 71 years old, and the follow-up time ranged from 24 to 30 months. There were 24 males and 16 females in Group B, aged from 51 to 76 years and the follow-up time ranged from 24 to 36 months. Hemoglobin level of the 3rd day after operation, transfusion rate, acetabular abduction angle, anteversion angle and creatine kinase level of the 3rd day after operation, Harris score of 3 months and the last time, VAS score of 1 week and the last time were recorded and compared. Complications were recorded at the final follow-up.
RESULTS:All patients were followed up, the follow-up time of SuperCap group ranged from 24 to 30 months, that of DAA group ranged from 24 to 36 months. No significant differences were found in hemoglobin level on the 3rd day after operation, transfusion rate, Harris score or VAS score between two group (P>0.05). There was no significant difference in Harris score between 3 months after operation and the final follow-up in both groups (P>0.05). There were no significant difference in VAS scores of 6 weeks after operation and on the final follow-up neither(P>0.05). The level of creatine kinase in SuperCap group was significant lower than that in DAA group(P<0.05). Until the final follow-up, there was no significant difference in the incidence of complications between the two groups(P>0.05).
CONCLUSION:The clinical effect of minimally invasive SuperCap approach after total hip arthroplasty is comparable to that of DAA approach with less soft tissue injury. Patients can recover rapidly after operation and it is a safe and effective surgical approach for surgeons with short learning curve.
